Cure models in survival analysis deal with populations in which a part of the individuals cannot experience the event of interest. Mixture cure models consider the target population as a mixture of susceptible and non-susceptible individuals.
Introduction
Survival analysis is an area of statistics dedicated to researching time-to-event data. This is one of the oldest areas of statistics, which dates back to the 1600s with the construction of life tables. The study of time-to-event data seems simple and traditional because its main focus is centered on non-negative random variables. But this is very far from being the case. The fact that survival times are always positive keeps it away from the normal distribution framework, censoring and truncation schemes produce nontraditional likelihood issues, and the special elements that generate the dynamic nature of events occurring in time make survival analysis an interesting and exciting area of research and application, mainly in the biomedical field.
Cure models in survival analysis deal with target populations in which a part of the individuals cannot experience the event of interest. This type of models have largely been developed as a consequence of the discovery and development of new treatments against cancer. The rationale of considering a cure subpopulation comes from the idea that a successful treatment removes totally the original tumor and the individual cannot experience any recurrence of the disease. These models allow to estimate the probability of cure, a key and valuable outcome in cancer research. This is not the case for the traditional survival models which consider that all the individuals in the population are at risk. As stated by 15 , it is important to bear in mind that cure is considered from a statistical, population point of view and not from an individual perspective.
Mixture cure models are the most popular cure models. They consider that the target population is a mixture of susceptible and non-susceptible individuals. The main interest focuses on the so called incidence model, that accounts for the probability of cure, and the latency model for the time-to-event in the susceptible subpopulation. A mixture model such as this is very attractive, easy to interpret, and allows to account for model complexity (frailties, time-dependent covariates, etc) in both incidence and latency terms 22 . Some studies in cancer research with this type of models are 31 who discussed data from trials in paediatric cancer conducted by the Children's Cancer Group, 26 who studied recurrences for breast cancer and readmissions for colorectal cancer, and 11 who centered on melanoma cancer. A very interesting review of these models up to date is 22 .
Cured models also appear in other areas of research. This is the case of split population models in economics 30 and limited-failure population life models in reliability 21 .
Bayesian inference always expresses uncertainty in terms of probability distributions 17;18 and uses Bayes' theorem as often as necessary in a sequential way to update all relevant information. Bayesian methodology is especially attractive for survival analysis due to its natural treatment of censoring and truncation schemes as well as the probabilistic quantification of relevant survival outcomes, such as survival probabilities, that they do not need to resort to asymptotic tools 12 .
Computation in Bayesian inference is a key issue that allows the approximate implementation of non-analytical posterior distributions. The integrated nested Laplace approximation (INLA) 28 is a recent methodology for doing approximate Bayesian inference in the framework of latent Gaussian models (LGM) 27 . These models are a special class of Bayesian additive models that cover a wide range of studies and applications 29 , and survival models in particular 20 . INLA, in comparison to Markov chain Monte Carlo (MCMC) methods, provides accurate and fast approximations to the relevant posterior marginal distributions.
INLA is very attractive and has very good properties but it also has some limitations.
In particular, INLA cannot fit mixture models 19 in a natural way because they are generally defined in terms of a combination of different distributions 9 . But in science, every constraint or difficulty becomes an opportunity for learning. On this matter, 2 and 9 propose the combination of INLA within MCMC for mixture models, in particular Gibbs sampling, and fit with INLA the relevant posterior conditional distributions. 8 extends these proposals and introduce Modal Gibbs sampling to accelerate the inferential process.
This paper focuses on the implementation of INLA in mixture cure models. A general mixture cure survival model with covariate information for the latency and the incidence model within a general scenario with censored and non-censored information is discussed. The fact that non-censored individuals undoubtedly belong to the uncured population is a valuable information that was incorporated in the inferential process.
The organization of this paper is as follows. Section 2 presents the main elements of mixture cure models and the two most popular mixture cure models, the Cox proportional hazards and the accelerated failure times models. Section 3 introduces the integrated nested Laplace approximation within the general framework of Bayesian inference.
Section 4 is the core of the paper and contains our INLA proposal for estimating mixture cure models. Section 5 applies our proposal to the statistical analysis of two benchmark data sets in the framework of clinical trials and bone marrow transplants, and discusses and compares the subsequent results with those from a MCMC implementation. The paper ends with some conclusions.
Mixture cure models
Let T * be a continuous and non-negative random variable that describes the time-to-event of an individual in some target population. Let Z be a cure random variable defined as Z = 0 if that individual is susceptible for experiencing the event of interest, and Z = 1 if she/he is cured or immune for that event. Cure and non cure probabilities are P (Z = 1) = η and P (Z = 0) = 1 − η, respectively. The survival function for individuals in the cured and uncured population, S c (t) and S u (t), t > 0, respectively, is
The general survival function for T * can be expressed in terms of a mixture of both cured and uncured populations in the form
It is important to point out that S u (t) is a proper survival function but S(t) is not. It goes to η and not to zero when t goes to infinity. Cure fraction η is also known as the incidence model and time-to-event T * u in the uncured population as the latency model 22 .
Covariates in the incidence model
The effect of a baseline covariate vector x 1 on the cure proportion is typically modeled by means of a logistic link function, logit[η(β 1 )] = β 1 x 1 , also expressed as
where β 1 is the vector of regression coefficients associated to x 1 . Note that other link functions can be used to connect the cure fraction with the vector of covariates x 1 such as the probit link or the complementary log-log link (see 25 for more details).
Covariates in the latency model
The most common regression models in survival analysis are the Cox proportional hazards model 5 and the accelerated failure time models. We will introduce them below.
Cox proportional hazards model, CPH. It is usually formulated in terms of the hazard function for the time-to-event T * u , or instantaneous rate of occurrence of the event, as
where h u0 (t) is the baseline hazard function that determines the shape of the hazard function. Model (4) can also be presented in terms of the survival function of T * u as
where S u0 (t) = exp{− selections. They provide a great flexibility to the modeling by allowing different patterns and multimodalities but some care is needed when working with them to avoid overfitting. To this effect, the elicitation of prior distributions is a relevant issue in the linear models to the survival framework. The survival variable T * u is now expressed in the logarithmic scale to extend the modeling to the real line. It is modeled as the sum of a linear term for the covariates x 2 , which usually includes an intercept element, and a random error amplified or reduced by a scale factor σ as followss
Common distributions for are normal, logistic and standard Gumbel. They respectively imply log-normal, log-logistic and Weibull distributions for T * u 4 . Weibull AFT models are the most popular ones, in which covariates x 2 are commonly included in the scale parameter as λ(β 2 ) = exp{β 2 x 2 }, and consequently
This modeling strategy based on introducing covariate information through one of the parameters of the target distribution also applies to the rest of parametric probability distributions.
Bayesian inference and the integrated nested Laplace approximation
Bayesian inference derives the posterior distribution of the quantities of interest according to Bayes' theorem, which combines the prior distribution of all unknown quantities and the likelihood function constructed from the data. It is the main element in Bayesian statistics and starting point of all relevant inferences. The posterior distribution in complex models is non analytical and for this reason it needs to be computationally approached. To that effect, MCMC methods are surely the most popular procedures although they involve large computational costs and require additional work for checking convergence and accuracy estimation.
The structure and main elements of the INLA approach for doing Bayesian inference are summarised below. Let us assume a set of n random variables T * = (T * 1 , . . . , T * n ) mutually conditionally independent given a latent Gaussian Markov random field (GMRF) 27 θ and a set of likelihood hyperparameters φ 2 . The GMRF θ depends on some hyperparameters φ 1 and can include effects of different type (regression coefficients, random effects, seasonal effects, etc).
According to Bayes' theorem, the joint posterior distribution for (θ, φ), where φ =
, where D i represents the data from individual ith, can be written as
where
is the likelihood function of (θ, φ) for data D i , and π(θ, φ)
represents the prior distribution of (θ, φ) which factorizes as the product of a GMRF conditional prior distribution π(θ | φ) and a marginal prior distribution π(φ).
INLA makes use of Laplace approximations 28 to obtain approximationsπ(φ | D) and
, respectively, where θ · denotes a generic univariate element in θ. The marginal posterior distribution for the latent terms π(θ · | D) can be obtained as
and consequently, it can be approximated by numerical integration as
where φ m are points in the hyperparametric space Φ, and ∆ m integration weights.
The posterior marginal distribution π(φ · |D ) can also be approximated by numerical integration according to the expression
where φ −· represents all elements in φ except φ · .
INLA is implemented in the package R-inla for the R statistical software 24 . This package implements a number of latent effects and allows for an easy model fitting and visualization of the output. A recent review on INLA and the can be found in 29 .
INLA to estimate mixture cure models
In general, standard survival models such as CPH and AFT models can be expressed in terms of GMRF models, and consequently they can be adapted for its INLA implementation 1;20 . In the case of CPH models, the baseline hazard function is reparameterized in the exponential scale in order to be included in the CPH element that accounts for regression information. This exponential term also allows the inclusion of time-varying covariate effects, nonlinear, structured or non random effects, spatial modelling, etc 10 . They can be expressed by means of a structured geoadditive predictor whose elements can be modeled in terms of a GMRF model. AFT models also have this nice relationship and behaviour for INLA implementation.
Gibbs sampler for mixture estimation
Let us consider a general survival scenario in the framework of non-informative and independent right censoring and a mixed cure sampling model. Survival time is defined as the pair (T, δ), where T = min(T * , C), C being the censoring time, and δ an indicator function defined as δ = 0 when the subsequent observation is censored (T * > C), and δ = 1 when it is not. We assume that the distribution of T * depends on a conditional GRMF θ on hyperparameters φ 1 and a likelihood hyperparametric vector φ 2 , and consider π(θ, φ) as the prior distribution for (θ, φ) which factorizes as
Let D i = (t i , δ i ) represent the survival observed data for individual i, i = 1, . . . , n, and 
As z is seldom observed, it is often treated as another parameter in the model and its posterior distribution needs to be computed as well. The posterior distribution for (θ, φ)
computed from Bayes' theorem would be
where L(θ, φ | D) is the likelihood function of (θ, φ) for the observed data D, and Z denotes the parameter space of the cure indicator values, which is the n-dimensional
Cartesian product of the binary set {0, 1}.
The introduction of the latent indicator in the inferential process and the Gibbs sampler is the usual procedure to approach Bayesian mixture estimation 6;19 . We follow this proposal and consider the inferential process defined by the joint posterior distribution 
INLA and modal Gibbs
Our proposal for fitting mixture cure models by means of INLA is based on 9 The posterior marginal distribution for each θ · can be computed as
where π(θ · | z, D) is fitted by INLA and π(z | D) is the marginal posterior distribution for the latent cure indicator vector based on the observed data. This latter distribution will be computed using modal Gibbs sampling as proposed by 8 . The computation of π(φ · | D) follows a similar procedure.
Expression (14) needs some additional discussion so that it can be better adapted to the cure models framework. Here, we know that each survival observation can be censored or uncensored. In the case of a censored data, we do not know if the subsequent individual can or cannot experience the event of interest, hence their belonging to the uncured or cured subpopulation is unknown and consequently, there will be uncertainty about the value of the corresponding cure indicator variable. Conversely, an uncensored observation will indicate that the subsequent individual has surely experienced the event of interest, and therefore she/he belongs to the uncured subpopulation. If we split z = (z unc , z cen ), where z unc (z cen ) represents the n unc (n cen )-dimensional latent cure indicator corresponding to the uncensored (censored) data, the complete knowledge on the value of the latent indicator of the uncensored data will imply z unc = 0. For this reason,
where now Z cen is the parameter space of the cure indicator variables for the censored observations, with lower dimensionality than Z. Hence, expression (14) can be rewritten
The above procedure can be described in a more structured way via the following algorithm:
Step 0. Assign initial values to the latent cure indicator of the n cen censored observations, z
cen , and consider z unc = 0 for the uncensored observations. Define
cen , z unc }.
Step 1. For m = 1, 2, . . . ,φ
).
Illustrative studies
We considered two benchmark datasets to illustrate our proposal for estimating mixture cure models via INLA. They are the so-called Eastern Cooperative Oncology Group (ECOG) phase III clinical trial e1684 dataset 14 and the bonemarrow transplant study dataset 13 . In both studies, we compared our results with the ones obtained via MCMC 
ECOG study
The ECOG phase III clinical trial was designed to compare a high dose interferon alpha- Incidence and latency model. We considered the same CPH mixture cure model stated by the authors in 14 . The cure proportion for individual ith in the incidence model was expressed in terms of a binary regression logistic model defined as
where β 0,1 represents the reference category, to be a man receiving ST treatment, and 
with Weibull baseline hazard function h u0 (t) = αt α−1 .
The model is completed with the elicitation of a prior distribution for all uncertainties it includes. We assume prior independence and select vague normal distributions centered at zero and variance 1,000 for all the regression coefficients in (16) and (17) as well as for log(λ). The elicited prior distribution for α is the gamma distribution Ga(0.01, 0.01), a very common election in these models which baseline hazard function is specified in terms of a Weibull distribution.
Posterior inferences Our algorithm configuration included 50 burn-iterations followed by other 450 iterations for inference. In addition, the simulations were thinned by storing one in five draws in order to reduce autocorrelation in the saved sample. The convergence was evaluated by examining whether the estimated conditional (on z) marginal loglikelihood achieved stability during the iteration steps of the algorithm.
INLA results were compared to those obtained via MCMC methods with the JAGS software. A MCMC algorithm was run considering three Markov chains with 100,000
iterations each and a burn-in period with 20,000 ones. In addition, the chains were thinned by storing one in two hundred iterations in order to reduce autocorrelation in the saved sample and avoid space computer problems. Convergence was assessed based on the potential scale reduction factor and the effective number of independent simulation draws 7 .
The number of iterations needed to accomplish convergence under our proposal is a fraction than the one in the MCMC configuration. This occurs because our algorithm only needs to explore the parameter space of the cure indicator variables corresponding to the censored observations, Z cen , and not the full parameter space Z. Futhermore, the profiles are very similar among the groups, but it seems that the best and worst survival expectations correspond to M-IFN and W-ST groups, respectively. We could conclude that the probability of cure is very different among the groups (see Table 2 ) but the uncured survival profiles of the individuals in the different groups are very similar (see Figure 1 ). 
Bone marrow transplant study
Next, we consider the bone marrow transplant study dataset in 13 The main goal of the study was to compare both groups, autologous and allogeneic, with regard to the incidence and the latency models. Covariate information only contemplates the type of transplant and was incorporated in both terms of the cure model.
Incidence and latency model
The cure probability for individual ith corresponding to the incidence model was expressed in terms of a regression logistic model defined as
where β All,1 represents the effect of the reference category, to be an individual who has received an allogeneic transplant, and I Aut (i) is an indicator variable with value 1 whether individual i has had an autologous graft.
Survival time for individual i in the uncured subpopulation, T ui , was modeled by means of a Weibull AFT model defined as
where now β All,2 represents the effect of receiving an allogeneic graft, and β Aut,1 the additional effect for having an autologous transplant.
The model is completed with the elicitation of a prior distribution for all parameters it contains. We assume prior independence and select vague normal distributions centered at zero and variance 1,000 for all the regression coefficients in the model except for α = 1/σ, for which a Ga(0.01, 0.01) distribution was selected.
Posterior inferences Our algorithm configuration for this model included 20 burn-in iterations and other 180 for inference. In addition, the simulations were thinned by storing every 2nd draws in order to reduce autocorrelation in the saved sample. Convergence was evaluated by examining whether the conditional marginal log-likelihood estimates achieved stability during the iteration steps of our algorithm.
MCMC simulation was run considering three Markov chains with 200,000 iterations and a burn-in period with 40,000 iterations. The chains were thinned by storing every 400th iteration to reduce autocorrelation in the saved sample and avoid space computer problems. Convergence was also here assessed via the potential scale reduction factor and the effective number of independent simulation draw 7 . As in the ECOG study, our proposed method here also needed less iterations than MCMC configuration to reach convergence and accurate results. In the case of the estimation of derived quantities of interest, we proceed analogously to the ECOG study. We estimate the INLA and MCMC posterior distribution for the cure proportion for allogeneic and autologous transplant patients (Table 4) as well as the subsequent posterior mean of the uncured survival function (Figure 2 ). Outcomes also now present scarce differences and underline that allogeneic transplanted patients seem to have cure proportion levels higher than the ones for autologous patients, although we also appreciate a very broad degree of overlap.
Conclusions
This paper discussed an INLA approach for dealing with mixture cure models based on a general procedure by 2;8;9 that extends INLA to finite mixture models. We introduced latent indicators in the inferential process for classifying individuals in the cured and uncured subpopulations, and approximated the relevant posterior distribution via Gibbs sampling. In particular, we use modal Gibbs sampling 8 On the other hand, MCMC provides, at the moment, slightly faster computational times and consequently, more research would be necessary to minimize computational efforts and storage requirements. Note that INLA estimates two complete models, incidence and latency, in each iteration. This leads to an important computational burden because two complete processes in each iteration were generated thus producing new temporary files and other secondary elements. So, if we limit the default outcomes provided by INLA and we define prior distributions based on the inferences from the previous iteration, computational savings could be achieved.
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